
ICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll
The Indian Council of Medical Research (ICMR) and Panacea Biotec on Wednesday announced the commencement of the Phase 3 clinical trial of India’s first indigenous dengue vaccine, DengiAll, at Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) Rohtak. Union Health Minister JP Nadda hailed the initiative, stating, “The initiation of this Phase…